All News
EULAR 2021 - Day 1 Podcasts
Check out this compilation of our EULAR 2021 Day 1 broadcasts below.
You can follow the EULAR 2021 RheumNow podcasts on iTunes and Soundclound.com
Listen by Clicking below:
Read Article
EULAR 2021 - Opening Day
RheumNow has begun covering EULAR 2021, the premier Rheumatology Congress that is usually held in Europe, but has gone virtual in 2021 because of the pandemic. We have several faculty members around the world reporting on the this year's meeting.
Please visit RheumNow.com daily for the latest videos, tweet summaries, news articles and podcasts emanating from EULAR.
Look for our coverage on these and other important topics:
#Digital #rheumatology in the era of #COVID-19: evidently increasing inclination of patients and physicians to use digital health apps for recording data- as informed by a national survey by @JK77775 and colleagues #EULAR2021 @ARD_BMJ https://t.co/Uo60qZurhG
Latika LatikaGupta_ ( View Tweet)
So it comes down to the grand question: how on earth do we actually monitor disease activity??
"We still don't have a failsafe algorithm... relapse is both underdiagnosed & overdiagnosed" - @Sarah_L_Mackie
The challenge lots of good people are working on!
#EULAR2021 @RheumNow https://t.co/PUa6Ly1DQw
David Liew drdavidliew ( View Tweet)
"But, effectively communicating overdiagnosis is a challenge in light of entrenched beliefs about the benefits of testing and the culture of current journalism practices." @raymoynihan et al in @BMJ_Open. https://t.co/1DW5OIMh6R
Ivan Oransky ivanoransky ( View Tweet)
Fascinating talk by Dr Tombetti on the potential use of arterial wall derived microvesicles collected from plasma as a means of non-invasive liquid biopsy in vasculitis @RheumNow #EULAR2021 Abstr#OP0056 https://t.co/Y6UO2mpjV0
Richard Conway RichardPAConway ( View Tweet)
Additional results from @rheum_covid trainee survey re: Telemedicine presented in AB0674:
📱dramatic ⬆️ in telemed (13% to 83%) during pandemic
📱limited training and supervision
📱trainees felt telemed negatively impacted supervision & clin teaching quality
#EULAR2021 https://t.co/44X5UprD7V
Kristen Young kristenyoung ( View Tweet)
Presented results from @rheum_covid Trainee Survey today at #EULAR21 (POS0051):
👎🏼 trainees felt multiple domains in clinical care & research were negatively impacted by pandemic
🔥 50% felt burntout with 68% with ⬆️ of work related stress
🗣@SuAnnYeoh1, @rheumed & team https://t.co/KXei6r6ZHn
Kristen Young kristenyoung ( View Tweet)
Our SLR on pathogenesis of SARS-CoV-2 Main findings: TH1 cytokines and IL-6 associated w/ severe COVID19 and fatal outcomes. ⬆️ classical blood monocytes and polyfunctional T cells. Impaired IFN response associated w/ poor outcomes. #POS0052 @Rheumnow #EULAR2021 @alessia_alunno https://t.co/PGph5IRBkX
Aurelie Najm AurelieRheumo ( View Tweet)
@jeffsparks wahooo! Congrats on the #EULAR2021 clinical science award recognition!
Dr. Rachel Tate uptoTate ( View Tweet)
#EULAR2021: AxSpA patients with greater patient-reported pain and spinal pain relative to axPsA patients among real-world patients in CorEVitas' Psa/Spa observational Registry per Dr. Mease's oral abstract presentation. @RheumNow https://t.co/YEdhd7x6cb
Meral K. El Ramahi, MD MeralElRamahiMD ( View Tweet)
#EULAR2021: "I am an advocate for smart T2T, not a mathematical T2T approach." - Dr. Filip van den Bosch @RheumNow
Meral K. El Ramahi, MD MeralElRamahiMD ( View Tweet)
Prof. Alten outlined the value of patient-reported outcomes for clinical practice!
How do you collect patient-reported outcomes - PRO - in your rheumatology clinic?
#EULAR2021 @RheumNow
Paul Studenic Stiddyo ( View Tweet)
Novel Results from the @rheum_covid register in #RA patients presented by @jeffsparks #OP0006
Higher risk for patients on rituximab or on JAK inhibitors for hospitalisation & ventilation or death after #COVID19 infection compared to TNFi users. #EULAR2021 @RheumNow https://t.co/40h5zVpxAO
Paul Studenic Stiddyo ( View Tweet)
Our meta-analysis on IA GC effects on pain and function in knee OA vs. controls at different time points: short term superiority of IA GC, medium term effect is no longer significant apart vs PBO and long term IA GC non superior vs controls. #EULAR2021 @RheumNow #POS1099 https://t.co/mQ0bMF03IT
Aurelie Najm AurelieRheumo ( View Tweet)
Hello @IainBMcInnes1, and thanks for your president's welcome to the #EULAR2021 portal!
Clean and straightforward, I like it. No tour required! @eular_org @RheumNow https://t.co/RDRl4FhEZj
David Liew drdavidliew ( View Tweet)
Starting Thursday we'll be covering EULAR. Tune in for coverage on KOL perspective highlights, clinical trial highlights and much more. https://t.co/L7ryiQ5HdV
Dr. John Cush RheumNow ( View Tweet)
@jeffsparks knocking it out of the park presenting our findings on b/tsDMARD associations with COVID-19 outcomes @eular_org @EULAR_Press check out our full paper just published in @ARD_BMJ https://t.co/jcA1LN45R3
Zach Wallace zach_wallace_md ( View Tweet)
Excellent talk by @LCalabreseDO on the balance of the immune response!
⭐️Exhausted T cells seen in rheumatic dz, chronic infections, cancers, severe COVID-19
⭐️CPI for treatment of latent infections? CPI for treatment of COVID? 🤔
Abs#OP7137 #EULAR2021 @RheumNow https://t.co/18rvFkpPTx
Robert B Chao, MD doctorRBC ( View Tweet)
Introducing EULAR's new name: 'European Alliance of Associations for Rheumatology' highlighting the importance of collaboration in the scientific community and bringing the patient’s voice across all bodies of work #EULAR2021 @rheumnow
k dao KDAO2011 ( View Tweet)
